Exane Derivatives’s Broadridge BR Stock Holding History

Exane Derivatives’s Portfolio BR Stock Details BR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$428	Hold	3	–	–	﹤0.01%	590
2022 Q1	$467	Hold	3	–	–	﹤0.01%	868
2021 Q4	$548	Hold	3	–	–	﹤0.01%	763
2021 Q3	$500	Hold	3	–	–	﹤0.01%	938
2021 Q2	$505	Hold	3	–	–	﹤0.01%	940
2021 Q1	$459	Sell	3 -2,974	-100%	-$439K	﹤0.01%	803
2020 Q4	$456K	Buy	2,977 +2,968	+32,978%	+$431K	0.13%	179
2020 Q3	$1.19K	Buy	+9	New	+$1.2K	﹤0.01%	603
2019 Q3	–	Sell	-5,731	Closed	-$731K	–	662
2019 Q2	$731K	Buy	+5,731	New	+$690K	0.13%	130
2017 Q1	–	Sell	-164	Closed	-$10.9K	–	586
2016 Q4	$10.9K	Hold	164	–	–	﹤0.01%	393
2016 Q3	$11.1K	Hold	164	–	–	﹤0.01%	392
2016 Q2	$10.7K	Buy	+164	New	+$10.2K	﹤0.01%	364

Other funds holding BR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JIM

Jensen Investment Management Lake Oswego, Oregon $4.13B AUM 8.88% 1-Year Est. Return

Exane Derivatives's BR Position: Q2 2022 in Review

Exane Derivatives held its Broadridge (BR) position steady in Q2 2022 at 3 shares worth $428. The position accounts for ﹤0.01% of the portfolio, ranked #590.

Exane Derivatives first reported a position in BR in Q2 2016 and has held it in 12 quarters since. The position peaked at $731K in Q2 2019. 763 funds tracked by Wall St. Rank hold BR as of Q2 2022.

Exane Derivatives held 3 shares of Broadridge worth $428 as of Q2 2022.
Exane Derivatives left its Broadridge share count unchanged in Q2 2022.
Broadridge made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #590 holding.
Exane Derivatives first reported a position in Broadridge in Q2 2016 and has held it in 12 quarters since.
Exane Derivatives's Broadridge position peaked at $731K in Q2 2019.
763 funds tracked by Wall St. Rank held Broadridge as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.